Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis.

作者信息

Beiske Antonie Giaever, Myhr Kjell-Morten

出版信息

J Neurol. 2006 Mar;253(3):377-8. doi: 10.1007/s00415-006-0898-0. Epub 2006 Mar 6.

DOI:10.1007/s00415-006-0898-0

PMID:16502214

Abstract

摘要

相似文献

Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis.

J Neurol. 2006 Mar;253(3):377-8. doi: 10.1007/s00415-006-0898-0. Epub 2006 Mar 6.

Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.

J Neurol. 2005 Jul;252(7):855-6. doi: 10.1007/s00415-005-0767-2. Epub 2005 Mar 8.

Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.

J Cutan Pathol. 2009 Mar;36(3):331-7. doi: 10.1111/j.1600-0560.2008.01019.x. Epub 2008 Aug 19.

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy.

Mult Scler. 2011 Apr;17(4):423-30. doi: 10.1177/1352458510394610. Epub 2011 Jan 10.

Calcified subcutaneous nodules: a long-term complication of interferon beta-1a therapy.

Br J Dermatol. 2007 Sep;157(3):624-5. doi: 10.1111/j.1365-2133.2007.08040.x. Epub 2007 Jun 26.

[Interferons beta in patients with multiple sclerosis].

Zh Nevrol Psikhiatr Im S S Korsakova. 2005;105(7):54-5.

Local pain during REBIF injection is not due to acidic pH.

J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1078. doi: 10.1136/jnnp.2003.025114.

Liver injury associated with the beta-interferons for MS: a comparison between the three products.

Neurology. 2004 Feb 24;62(4):628-31. doi: 10.1212/wnl.62.4.628.

Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.

Acta Derm Venereol. 2001 May;81(2):152. doi: 10.1080/00015550152384407.

[Logistics and description of treatment technology (the protocol for using disease modifying drugs--DMD)].

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):93-8.

引用本文的文献

Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports.

Curr J Neurol. 2023 Apr 4;22(2):115-136. doi: 10.18502/cjn.v22i2.13340.

A CASE OF ACQUIRED GENERALIZED LIPODYSTROPHY ASSOCIATED WITH PEMBROLIZUMAB IN A PATIENT WITH METASTATIC MALIGNANT MELANOMA.

AACE Clin Case Rep. 2020 Jan 3;6(1):e40-e45. doi: 10.4158/ACCR-2019-0234. eCollection 2020 Jan-Feb.

Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?

Neuropsychiatr Dis Treat. 2012;8:465-73. doi: 10.2147/NDT.S36771. Epub 2012 Oct 23.

Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.

J Neurol Neurosurg Psychiatry. 2006 Dec;77(12):1382-3. doi: 10.1136/jnnp.2006.094813. Epub 2006 Jun 16.

本文引用的文献

Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.

Can J Neurol Sci. 2004 Feb;31(1):58-63. doi: 10.1017/s0317167100002845.

Skin necrosis following a recombinant interferon-beta-1b injection.

Chang Gung Med J. 2002 Nov;25(11):774-7.

Lipoatrophy associated with glatiramer acetate injections for the treatment of multiple sclerosis.

Cutis. 2001 Oct;68(4):287-8.

Multiple sclerosis.

N Engl J Med. 2000 Sep 28;343(13):938-52. doi: 10.1056/NEJM200009283431307.

Localized lipoatrophy after prolonged treatment with copolymer 1.

J Neurol. 2000 Mar;247(3):220-1. doi: 10.1007/s004150050568.

Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis.

Arch Dermatol. 1999 Oct;135(10):1277-8. doi: 10.1001/archderm.135.10.1277.

Severe necrotising cutaneous lesions complicating treatment with interferon beta-1a.

J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):115. doi: 10.1136/jnnp.67.1.115.

Lipoatrophy induced by recombinant human insulin injection.

Intern Med. 1998 Dec;37(12):1031-3. doi: 10.2169/internalmedicine.37.1031.

Interferon beta-1b injection site reactions and necroses.

Mult Scler. 1998 Apr;4(2):70-3. doi: 10.1177/135245859800400205.

Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b.

N Engl J Med. 1995 Jun 8;332(23):1584. doi: 10.1056/NEJM199506083322316.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验